» Articles » PMID: 33575575

A Functional Network of Gastric-cancer-associated Splicing Events Controlled by Dysregulated Splicing Factors

Abstract

Comprehensive understanding of aberrant splicing in gastric cancer is lacking. We RNA-sequenced 19 gastric tumor-normal pairs and identified 118 high-confidence tumor-associated (TA) alternative splicing events (ASEs) based on high-coverage sequencing and stringent filtering, and also identified 8 differentially expressed splicing factors (SFs). The TA ASEs occurred in genes primarily involved in cytoskeletal organization. We constructed a correlative network between TA ASE splicing ratios and SF expression, replicated it in independent gastric cancer data from The Cancer Genome Atlas and experimentally validated it by knockdown of the nodal SFs (,  and ). Each SF knockdown drove splicing alterations in several corresponding TA ASEs and led to alterations in cellular migration consistent with the role of TA ASEs in cytoskeletal organization. We have therefore established a robust network of dysregulated splicing associated with tumor invasion in gastric cancer. Our work is a resource for identifying oncogenic splice forms, SFs and splicing-generated tumor antigens as biomarkers and therapeutic targets.

Citing Articles

A Systematic Identification of RNA-Binding Proteins (RBPs) Driving Aberrant Splicing in Cancer.

Lobato-Fernandez C, Gimeno M, San Martin A, Anorbe A, Rubio A, Ferrer-Bonsoms J Biomedicines. 2024; 12(11).

PMID: 39595158 PMC: 11591948. DOI: 10.3390/biomedicines12112592.


Comprehensive Analysis of Alternative Splicing in Gastric Cancer Identifies Epithelial-Mesenchymal Transition Subtypes Associated with Survival.

Jun Y, Suh Y, Park S, Lee J, Kim J, Lee S Cancer Res. 2021; 82(4):543-555.

PMID: 34903603 PMC: 9359730. DOI: 10.1158/0008-5472.CAN-21-2117.


Tumorigenic de-differentiation: the alternative splicing way.

Ray D, Epstein D Mol Cell Oncol. 2020; 7(6):1809959.

PMID: 33235913 PMC: 7671003. DOI: 10.1080/23723556.2020.1809959.


A tumor-associated splice-isoform of drives dedifferentiation in MBNL1-low cancers via JNK activation.

Ray D, Yun Y, Idris M, Cheng S, Boot A, Iain T Proc Natl Acad Sci U S A. 2020; 117(28):16391-16400.

PMID: 32601196 PMC: 7368273. DOI: 10.1073/pnas.2002499117.

References
1.
Wang W, Dong L, Zhang N, Zhao C . Role of cancer stem cell marker CD44 in gastric cancer: a meta-analysis. Int J Clin Exp Med. 2015; 7(12):5059-66. PMC: 4307452. View

2.
Bates D, Morris J, Oltean S, Donaldson L . Pharmacology of Modulators of Alternative Splicing. Pharmacol Rev. 2016; 69(1):63-79. PMC: 5226212. DOI: 10.1124/pr.115.011239. View

3.
MacGrath S, Koleske A . Cortactin in cell migration and cancer at a glance. J Cell Sci. 2012; 125(Pt 7):1621-6. PMC: 3346822. DOI: 10.1242/jcs.093781. View

4.
Wahl M, Luhrmann R . SnapShot: Spliceosome Dynamics I. Cell. 2015; 161(6):1474-e1. DOI: 10.1016/j.cell.2015.05.050. View

5.
Shi J, Qian W, Yin X, Iqbal K, Grundke-Iqbal I, Gu X . Cyclic AMP-dependent protein kinase regulates the alternative splicing of tau exon 10: a mechanism involved in tau pathology of Alzheimer disease. J Biol Chem. 2011; 286(16):14639-48. PMC: 3077661. DOI: 10.1074/jbc.M110.204453. View